Puff Puff Post

SEPTEMBER 16, 2019

Media are invited to attend an open house to learn more about the program and visit the recently expanded Santé Cannabis clinic and research centre in Montréal including a guided tour. RSVP: If you’d like to attend, please RSVP with Lilia Rassoul ( media@santecannabis.ca ). 71,000+ interactions with healthcare professionals.

Programs 108

Programs Research and Development Education Treatment 108

Puff Puff Post

MARCH 2, 2020

Source: New Frontier Data). · Domestic quotas represent a further milestone in the Company’s stated timeline to bring the first medical cannabis products to market in Colombia, targeting patients with two priority conditions; chronic pain and nausea associated with chemotherapy. SOURCE Khiron Life Sciences Corp.

Extraction 52

Extraction THC Chronic Pain Cultivation 52

SpeedWeed

APRIL 23, 2021

While the cannabis community was reveling in its celebration of the plant, Talarico turned to social media to share the news of a bill he filed last month. To back up his push for Texas cannabis legalization, he went on to share public opinion data collected by the Texas Tribune in a recent survey, tweeting “this is a popular bipartisan idea.

Legalization 52

Legalization Chronic Pain Policy Legislation 52

Cannabis Law Report

DECEMBER 20, 2021

Data To Support Regulatory Filings in the United States. Virpax” or the “Company”) (NASDAQ: VRPX), a company specializing in developing product candidates for pain management, CNS disorders and anti-viral indications, signed a clinical trial agreement with Altasciences Company, Inc., Media: Laura Radocaj. BERWYN, Pa.–(BUSINESS

Clinical Trials 40

Clinical Trials Chronic Pain Pharmaceutical Data 40

Puff Puff Post

MARCH 2, 2020

Source: New Frontier Data). · Domestic quotas represent a further milestone in the Company’s stated timeline to bring the first medical cannabis products to market in Colombia, targeting patients with two priority conditions; chronic pain and nausea associated with chemotherapy. SOURCE Khiron Life Sciences Corp.

Extraction 40

Extraction THC Chronic Pain Cultivation 40

Cannabis Law Report

MAY 6, 2022

The FDA’s warning letters tell the public that the FDA reads and reviews companies’ websites, labels, social media, and marketing language. The FDA evaluates sellers’ claims, graphics, and product descriptions – including products marketed for animals, information about food additives, and social media websites.

THC 52

THC CBD Media Food 52

Cannabis Law Report

NOVEMBER 9, 2021

Delic expects to drive considerable patients to KWC through its media platform and build on the existing national leadership position already in place. Delic has been focused on opening locations in secondary cities with considerable demand, in an effort to provide access to the most patients. Transaction Summary.

Treatment 52

Treatment Therapy Media Access 52

Cannabis Law Report

NOVEMBER 10, 2021

The NIH has also engaged a firm to manufacture Leu-enkephalin (L-ENK), the active ingredient in Envelta and a firm to manufacture the Molecular Envelope Technology (MET) that is used to carry the L-ENK to the brain to promptly suppress pain. Media: Laura Radocaj. In October 2021, Virpax announced that a $1.87 Christopher M. Betsy Brod.

Research and Development 40

Research and Development Chronic Pain Pharmaceutical Clinical Trials 40

Cannabis Law Report

DECEMBER 8, 2021

This data should strengthen the Company’s IND filing in advance of the anticipated start of first-in-human clinical trials. Probudur™ is a single injection long-acting liposomal bupivacaine formulation being developed to manage post-operative pain. Media: Laura Radocaj. Christopher M. Chipman, CPA. Betsy Brod.

Clinical Trials 40

Clinical Trials Chronic Pain Pharmaceutical Topical 40

Kind Meds (Cannabis Education Blog)

FEBRUARY 24, 2022

was created to perpetuate this stereotype, the federal government had initiated a federal ban, and media portrayal of its so-called ill-effects helped convince many legislators to vote in its favor. Throughout the 20th century, the “stoner” stereotype was often portrayed in the media. The journal of headache and pain , 19 (1), 1-28.

Marijuana 52

Marijuana Research and Development Sleep Strains 52

Cannabis Law Report

NOVEMBER 24, 2021

Media representations can offer insights into the nature of the discourse about new medical products and therapies and how ideas and understandings about social phenomena become constructed. At the same time, the outlook on cannabis research data is largely positive. Media framing of cannabis. Background.

Research and Development 52

Research and Development Medicine Access Media 52

Cannabis Law Report

SEPTEMBER 13, 2021

Positive data from this important study would significantly advance MYMD-1’s potential to become a blockbuster drug for inflammation and aging.”. The Company’s second drug platform, Supera-CBD, is being developed to treat chronic pain, addiction and epilepsy. Media: media@mymd.com. Chief Scientific Officer.

Clinical Trials 40

Clinical Trials Pharmaceutical Research and Development Therapy 40

Cannabis Law Report

DECEMBER 14, 2021

There are 28 million people suffering from chronic pain in the UK and this range of formulations offers pain doctors the best and most comprehensive selection of cannabinoid treatment options for their patients. Media Lindsay Wilson. media@col-care.com. Investor Lee Ann Evans. Investor Relations. 1.212.271.0915.

Extraction 40

Extraction Patients Medicine Tincture 40

Cannabis Law Report

JULY 12, 2019

As reported in the Guardian, Analytical Cannabis emphasises the importance of this for those suffering from conditions such as chronic pain, epilepsy and neurological and psychiatric disorders who have long been seeking access to what they hope is a transformative medicine.

Epilepsy 40

Epilepsy Medicine Clinical Trials Chronic Pain 40

Puff Puff Post

SEPTEMBER 16, 2019

Media are invited to attend an open house to learn more about the program and visit the recently expanded Santé Cannabis clinic and research centre in Montréal including a guided tour. RSVP: If you’d like to attend, please RSVP with Lilia Rassoul ( media@santecannabis.ca ). 71,000+ interactions with healthcare professionals.

Programs 40

Programs Research and Development Education Treatment 40

MMJ Recs

MAY 3, 2024

From chronic pain to PTSD, patients with qualifying medical conditions have found solace in medical marijuana where traditional treatments may have fallen short. Online Forums and Communities: Online forums and social media groups dedicated to medical marijuana patients can be valuable sources of information and support.

Marijuana 52

Marijuana Treatment Compliance Compliance 52

StrainConnect

APRIL 23, 2019

Myrcene is also excellent for reducing inflammation and chronic pain and is a great way to open your receptors to accept cannabinoids. Please email support@strainconnect.com or try us on social media. Dont modify these 3 pswp__item elements, data is added later on. -->. Thats something to cheers to. ??. Share by:

Terpenes 63

Terpenes Cannabinoids Therapy Sativa 63

The Cannigma

OCTOBER 22, 2023

The Cannigma has always taken a data-informed approach to content creation – though up until recently we’ve been primarily leaning on the existing peer-reviewed literature to guide our content. We need more data – human data – on specific applications for the plant – symptoms, use cases, conditions and patient types.

Data 88

Data Research and Development Sleep Collective 88

Cannabis Law Report

SEPTEMBER 1, 2022

AUSTIN, Texas, August 31, 2022 –( BUSINESS WIRE )–As Pain Awareness Month begins, Texas Original is calling on Texas’ legislature to add chronic pain as a qualifying condition to the state’s Compassionate Use Program (CUP). 1 reason patients seek medical cannabis is to augment their pain management treatment.

Chronic Pain 52

Chronic Pain Programs Patients Conditions 52

Cannabis Law Report

AUGUST 31, 2022

AUSTIN, Texas–(BUSINESS WIRE)–As Pain Awareness Month begins, Texas Original is calling on Texas’ legislature to add chronic pain as a qualifying condition to the state’s Compassionate Use Program (CUP). Chronic pain is one of the most prevalent and provable conditions that medical cannabis can positively impact.

Chronic Pain 40

Chronic Pain Programs Patients Conditions 40

Cannabis Law Report

JULY 24, 2019

1 We have also reviewed your social media websites at www.facebook.com/CuraleafHemp External Link Disclaimer and [link] External Link Disclaimer ; these websites direct consumers to your website, [link] External Link Disclaimer , to purchase your products. Chronic or arthritic pain.”. Chronic pain.

CBD 51

CBD Tincture Pets Chronic Pain 51

The Cannigma

APRIL 8, 2021

CP: I’m going to say yes and it’s hard to tie this together, but there’s actually some really good animal, and a little bit of human data to support this. I postulate that that is correlated to our endocannabinoid system, which good data is now suggesting, is dysregulated in metabolic syndrome: obesity, diabetes, heart disease.

Medicine 108

Medicine Cannabinoids Cannabis THC 108

Weedistry

JANUARY 28, 2019

The data also indicate that fentanyl and other fentanyl-related substances continue to be a major driver of this crisis,” Health Canadanotes. It’s when presented with personal stories like that of the Rhodes family and the stream of alarming data that the significance of Tetra Bio-Pharma’s (TBP) clinical trials is worth exploring.

Clinical Trials 40

Clinical Trials Research and Development Chronic Pain Data 40

Cannabis Law Report

SEPTEMBER 19, 2019

CBD does not create the same high as THC and can be used for chronic pain and anxiety relief, according to Harvard Medical School. The perplexing narrative of vaping-related lung illnesses escalated into a full-blown national media frenzy last week with news that a fifth person had died from alarming pulmonary symptoms.

Vaping 55

Vaping Hemp Education Patients 55

StrainConnect

FEBRUARY 8, 2019

Please email support@strainconnect.com or try us on social media. Dont modify these 3 pswp__item elements, data is added later on. -->. Well keep you up to date with the latest CBD and cannabis educational resources, app features and industry news.without spam! Oops, there was an error sending your message. • 24 Apr, 2019.

Hemp 57

Hemp CBD Cannabinoids Sativa 57

FloridaMarijuana.net

AUGUST 13, 2018

Even mainstream media has profiled the medicinal effects of cannabis. No data was collected on sex or race/ethnicity. Almost all respondents (97%) used medical cannabis primarily for relief of chronic pain. Sleep improvement is a primary motivator for many patients who are utilizing medical cannabis. The mean age was 49.3

Sleep 180

Sleep Marijuana Chronic Pain Cannabinoids 180

The Cannigma

JANUARY 19, 2022

We think now that as more and more data is becoming available, the cannabis could be a very useful treatment both THC and CBD have shown promise in helping with the inflammation and some of the damage that has occurred in the brain. Does your social media activity kind of fall into that a lot and what other channels are you using?

Patients 83

Patients Compliance Compliance Cannabis 83